MPLT insider trading — MapLight Therapeutics, Inc.
Over the last 90 days, insiders at MapLight Therapeutics, Inc. (MPLT) made 1 open-market purchase worth $149K and 0 open-market sales worth $0, making them net buyers by $149K. The largest purchase was by Cox Troy (Director), who bought 15,620 shares for $149K on Jul 28, 2026.
Updated Oct 16, 2026.
Recent MPLT insider transactions
Every Form 4 filed by MapLight Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Hanson Kristopher | General Counsel | S · Sale · 10b5-1 | Direct | 16,509 | $11.67 | $193K | Form 4 |
| Aug 17, 2026 | Kroeger Christopher A. | Chief Executive Officer | A · Grant/award | Direct | 23,145 | — | — | Form 4 |
| Aug 17, 2026 | Gillis Jonathan | CAO and Interim CFO | A · Grant/award | Direct | 8,242 | — | — | Form 4 |
| Aug 17, 2026 | Lillie James Woodruff | Chief Scientific Officer | A · Grant/award | Direct | 7,730 | — | — | Form 4 |
| Aug 17, 2026 | Hanson Kristopher | General Counsel | A · Grant/award | Direct | 7,730 | — | — | Form 4 |
| Aug 17, 2026 | Kreitzer Anatol | Chief Discovery Officer | A · Grant/award | Direct | 6,020 | — | — | Form 4 |
| Aug 17, 2026 | Foff Erin Pennock | Chief Medical Officer | A · Grant/award | Direct | 13,360 | — | — | Form 4 |
| Aug 3, 2026 | Lillie James Woodruff | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 22,082 | $12.54 | $277K | Form 4 |
| Jul 28, 2026 | Cox Troy | Director | P · Purchase | Indirect | 15,620 | $9.52 | $149K | Form 4 |
| Jul 17, 2026 | Gillis Jonathan | CAO and Interim CFO | S · Sale · 10b5-1 | Direct | 18,469 | $37.60 | $694K | Form 4 |
| Jul 17, 2026 | Kreitzer Anatol | Chief Discovery Officer | S · Sale · 10b5-1 | Direct | 17,173 | $37.60 | $646K | Form 4 |
| Jul 16, 2026 | Gillis Jonathan | CAO and Interim CFO | S · Sale · 10b5-1 | Direct | 8,455 | $36.80 | $311K | Form 4 |
| Jul 16, 2026 | Kreitzer Anatol | Chief Discovery Officer | S · Sale · 10b5-1 | Direct | 9,056 | $36.80 | $333K | Form 4 |
| Jul 15, 2026 | Gillis Jonathan | CAO and Interim CFO | S · Sale · 10b5-1 | Direct | 10,055 | $36.51 | $367K | Form 4 |
| Jul 15, 2026 | Kreitzer Anatol | Chief Discovery Officer | S · Sale · 10b5-1 | Direct | 10,055 | $36.49 | $367K | Form 4 |
MPLT insider trading FAQ
Are insiders buying MPLT stock?
Yes. In the last 90 days, MapLight Therapeutics, Inc. insiders made 1 open-market purchase totaling $149K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading MPLT?
Recent buyers: Cox Troy.
Where does MPLT insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.